CN104530241B - A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application - Google Patents
A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application Download PDFInfo
- Publication number
- CN104530241B CN104530241B CN201410776634.6A CN201410776634A CN104530241B CN 104530241 B CN104530241 B CN 104530241B CN 201410776634 A CN201410776634 A CN 201410776634A CN 104530241 B CN104530241 B CN 104530241B
- Authority
- CN
- China
- Prior art keywords
- cell
- pep
- swine fever
- virus
- fever virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention provides a kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application, the present invention provides a kind of genetic engineering bacterium,E. coli BL21/ pET‑32a–CSFR, CCTCC NO:M2014631.The bacterial strain can be with expressing protein transduction structural domain polypeptide(PEP‑1)With swine fever virus receptor(CD46)1 CD46 of genetic engineering fusion protein PEP.Its advantage is that expression quantity is big, and soluble protein is at low cost, and security is good.The 1 CD46 albumen of PEP of expression can pass through the mediating proteins of cell membrane as swine fever virus, improve the virus titer of cell culture swine fever virus, can solve in current swine fever virus cell vaccine that viral level is low, the shortcomings that being not achieved with seedling standard.
Description
Technical field
The invention belongs to genetic engineering field, specifically, a kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and
Using.
Technical background
Swine fever (classical swine fever, CSF) is by swine fever virus (classical swine fever
Virus, CSFV) cause acute one kind of pig, heat generation, lethal infectious diseases.The disease has high degree in contact infectiousness, Zeng Guo
It is widely current on border, incidence is high, and the death rate is up to more than 90%, very harmful, and huge warp is caused to pig breeding industry at that time
Ji loss, important livestock and poultry infectious disease register is included in by the World Health Organization (OIE).At present, China is hog cholera vaccine life in the world
Production and most commonly used country, annual total flow is about more than 4,000,000,000 parts, and market total price is about 2,000,000,000 yuans.
The interference of prolonged vaccine immunity and other epidemic diseases, pig are gradually even generating hog cholera vaccine by generation
Tolerance, responsing reaction decrease or slack-off, causes the situation of hog cholera vaccine immuning failure in recent years often to occur, mild
Swine fever, inferior clinical symptom swine fever are constantly popular, annual therefore to cause nearly 10,000,000,000 yuan of economic losses to China's pig breeding industry.This shape
Gesture proposes the quality of hog cholera vaccine new requirement, and there is an urgent need for improve the potency of China's hog cholera vaccine.
The potency of hog cholera vaccine and the incubation of swine fever virus have an extremely close relationship, swine fever virus rely on it is quick
The surface receptor of sense cell is combined into cell, expand be released to again in culture solution in the cell [Wang Zhen, Lu Yu, Zhou Pengcheng,
Wait research [J] microorganism journals of swine fever virus reproductive process in PK cells and MPK cells, 1999,39 (3):189-
194.].But in incubation, even the allogenic cell in same culture vessel, and not all cell individual is all
Susceptible to the virus of inoculation, this is that is, after cell inoculation virus in same culture vessel, and in not all cell body
Will have cell entry amplification, and during swine fever virus culture, only small part cell has a cell entry, most cells be
Slowly increase cell quantity [Wang Zhen, Lu Yu, the bright filial piety swine fever virus China of fourth into virus with the extension of incubation time
Research [J] CHINA virus of rabbitization attenuated vaccine strain multiplication characteristic in primary bull testis cell, 2000,15 (23):170-
179.].This has resulted in two results:1st, initial period is cultivated, participates in that the cell of amplicon virus is less, and virus titer is difficult to rise
Height, 2, the speed of cell amplicon virus it is asynchronous, under cultivation temperature, first the viral viability that is released from cell declines,
This causes culture solution to reach the time lengthening of standard poison valency.It is therefore believed that:How the disease that in same culture vessel is inoculated with is made
Poison, which enters within the time as short as possible in most cell individuals, to be expanded, it would be possible to be the pass for obtaining high-titer swine fever virus
Key.
PEP-1 is a kind of film transducin, is also membrane-spanning protein, which can freely come in and go out cell membrane, and people make
Some drugs that cannot penetrate cell membrane are brought into the albuminoid, preferable effect is achieved in cell membrane, and CD46 albumen is then
It is pig plague virus specific receptor, specificity can captures swine fever virus in culture solution.Patent of the present invention uses both albumen
The mode of gene expression connects, and the swine fever virus in culture solution, then wearing by PEP-1 albumen are captured by CD46 albumen
Film effect brings the swine fever virus of capture into the cell into, makes in a short time to import swine fever virus by force in cultivating system and to the greatest extent may be used
Being expanded into the cell more than energy, achievees the purpose that increase substantially swine fever virus culture potency.
SAPGTP is a kind of fusion protein connector, is also connection peptide, will both active functional protein connect,
After structure forms fusion protein, each albumen can keep respective activity.Connection can correctly be folded by ensureing the polypeptide chain of the two
It is together and still active, but the activated centre that can make the two is away from each other, will not form steric hindrance and influence the table of activity
It is existing, activity can not be made to influence each other even and inhibited.Compared by the method for computer Blast search, it is predicted that SAPGTP connectors
The expression quantity of the fusion protein can not be interfered with well by together with PEP-1 membrane-spanning proteins and CD46 protein fusions, it will not
The correct of different structure territory in fusion protein is influenced to fold and corresponding biological activity.
The content of the invention
Object of the present invention is to provide a kind of recombinant protein PEP-1-CD46 that can improve swine fever virus culture potency,
Its sequence is shown in SEQ ID NO.2, corresponding nucleotides sequence is classified as shown in SEQ ID NO.1.PEP-1 is worn film egg by the present invention
In vain with CD46 protein fusion expressions, biologically active PEP-1-CD46 albumen is obtained, culture solution is captured using CD46 albumen
In swine fever virus, then the swine fever virus of capture is brought into the cell by the membrane penetration effect of PEP-1 albumen, made in cultivating system
Swine fever virus is imported by force in a short time it is as much as possible expand into the cell, reach increase substantially swine fever virus training
Support the purpose of potency.
It is another object of the present invention to provide a kind of cell-penetrating peptides that can improve swine fever virus culture potency to merge egg
White preparation method, this method can be applied in production of vaccine, and expression quantity is big, easy to operate, at low cost.The fusion protein can have
Effect improves the cultivation effect of swine fever virus in the cell, improves the malicious valency of Virus culture.
It is yet a further object of the present invention to provide a kind of Recombinant organism strain Escherichia coli
(Escherichia coli)BL21(DE3)pET-32a-PEP-1-CD46.The bacterial strain can be more with expressing protein transduction structural domain
Peptide (PEP-1) and swine fever virus receptor (CD46) genetic engineering fusion protein PEP-1-CD46.Its advantage is that expression quantity is big, solvable
Property albumen, at low cost, security is good.The bacterium is sent to China typical culture collection center in being preserved on December 5th, 2014
Preservation is carried out, deposit number is CCTCC NO:M2014631, address:Wuhan, China Wuhan University, Classification And Nomenclature:
Escherichia coli BL21(DE3)/pET-32a–CSFR。
PEP-1-CD46 protein sequences are as follows:
KETWWETWWTEWSQPKKKRKVSAPGTPMMAFCALRKALPCRPENPFSSRCFVEILWVSLALVFLLPMPS
DACDEPPKFESMRPQFLNTTYRPGDRVEYECRPGFQPMVPALPTFSVCQDDNTWSPLQEACRRKACSNLPDPLNGQV
SYPNGDMLFGSKAQFTCNTGFYIIGAETVYCQVSGNVMAWSEPSPLCEKILCKPPGEIPNGKYTNSHKDVFEYNEVV
TYSCLSSTGPDEFSLVGESSLFCIGKDEWSSDPPECKVVKCPYPVVPNGEIVSGFGSKFYYKAEVVFKCNAGFTLHG
RDTIVCGANSTWEPEMPQCIKDSKPTDPPATPGPSHPGPPSPSDASPPKDAESLDGGIIAAIVVGVLAAIAVIAGGV
YFFHHKYNKKRSK
PEP-1-CD46 nucleotide sequences:
AAGGAAACATGGTGGGAAACGTGGTGGACTGAGTGGTCCCAGCCTAAAAAGAAGAGAAAGGTTTCTGCT
CCAGGTACCCCTATGATGGCTTTCTGTGCTTTGCGTAAAGCTCTGCCATGTCGTCCAGAAAACCCATTTTCTTCTCG
TTGTTTCGTCGAAATATTGTGGGTTTCTTTGGCTTTGGTTTTTCTATTGCCAATGCCTTCTGATGCCTGTGATGAAC
CACCCAAGTTTGAATCTATGAGACCACAGTTCTTAAACACTACTTATAGGCCAGGTGATAGAGTCGAATACGAATGT
AGACCTGGTTTTCAACCAATGGTTCCAGCCTTGCCAACTTTTTCTGTTTGCCAAGACGATAATACTTGGTCTCCATT
GCAAGAAGCTTGTAGGAGAAAAGCTTGCTCTAATTTGCCAGATCCATTGAACGGTCAAGTTTCTTACCCAAATGGTG
ACATGTTGTTTGGTTCTAAAGCCCAATTTACGTGTAACACAGGTTTTTACATTATTGGTGCTGAAACTGTTTACTGC
CAAGTCTCTGGTAATGTCATGGCATGGTCCGAACCCTCTCCCTTGTGTGAAAAGATTTTGTGTAAGCCACCCGGTGA
AATTCCTAACGGTAAGTACACTAACTCTCATAAGGATGTTTTTGAGTATAACGAGGTCGTTACTTACTCTTGTTTGT
CTTCCACGGGACCAGATGAGTTTTCCTTGGTTGGTGAATCTTCTCTGTTTTGTATAGGTAAGGACGAATGGTCTTCT
GACCCACCCGAGTGTAAGGTTGTTAAGTGCCCATACCCAGTTGTTCCCAACGGAGAAATTGTTAGTGGTTTCGGTTC
AAAGTTCTATTACAAAGCAGAAGTCGTATTTAAGTGTAACGCCGGTTTTACTTTGCATGGTAGAGATACTATTGTCT
GTGGTGCTAATTCTACTTGGGAGCCAGAAATGCCACAATGTATTAAGGATTCTAAACCAACTGATCCACCAGCTACT
CCTGGTCCATCCCATCCAGGCCCACCCTCCCCATCAGATGCTTCTCCACCAAAGGATGCTGAATCATTGGACGGTGG
TATTATAGCCGCTATTGTTGTTGGTGTTTTAGCTGCAATAGCTGTCATTGCTGGAGGTGTGTATTTCTTCCATCACA
AATACAACAAAAAGAGGTCTAAGTAA
The PEP-1-CD46 fusion proteins that final object of the present invention is to provide recombination engineering expression are improving disease
Application in the malicious valency of poison culture, especially for the application in the culture of swine fever virus.
In order to achieve the above object, the present invention takes following technical measures:
The invention also discloses the methods of Prepare restructuring engineering bacteria, and this method comprises the following steps:
1) preparation of fusion PEP-1-CD46:According to the artificial synthesized PEP-1- of the gene order announced on GeneBank
CD46 genes;
2) structure of expression vector:With EcoR I and BamH I double digestion PEP-1-CD46cDNA and plasmid pET-32a (purchase
From Novagen companies), glutinous end connection is carried out with PET-32a plasmids under the action of T4 ligases, converts escherichia coli DH5a
(being purchased from Novagen companies) competent cell, picking single bacterium colony carry out PCR identifications, plasmid, reference are extracted in a small amount with alkaline lysis
《Molecular Cloning:A Laboratory guide》It carries out, DNA output is between 100ng and 5 μ g, depending on the copy number of plasmid.To the matter of extraction
Grain carries out digestion identification, and obtained positive colony is named as pET-32a-PEP-1-CD46.
3) preparation of Recombinant organism:Plasmid pET-32a-PEP-1-CD46 is converted into e. coli bl21
(DE3) competent cell (purchased from Novagen companies).PCR evaluation and screenings go out positive transformant, and picking positive colony single bacterium is dropped into
Row culture, final engineering bacteria (present invention or the recombination engineered strain Esche for obtaining stability and high efficiency expression PEP-1-CD46
Richia coli BL21 (DE3) pET-32a-PEP-1-CD46), which send to China in being preserved on December 5th, 2014
Type Tissue Collection carries out preservation, and deposit number is CCTCC NO:M2014631, address:Wuhan, China Wuhan University,
Classification And Nomenclature:Escherichia coli BL21(DE3)/pET-32a–CSFR.
The bacterial strain belongs to gram-Negative bacillus, no brood cell, and whole body flagellum can move.Optimum growth temperature is 37 DEG C, can
With IPTG or the automatic induced expression of lactose, it is metabolized vigorous.The bacterium anabolism ability is strong, containing inorganic salts, amine salt, glucose
Well-grown on ordinary culture medium, the various saccharides that can ferment production acid, aerogenesis.Its bacterium colony is rounded, and there is light on neat in edge, surface
Pool moistens, is smooth, translucent.
A kind of cell-penetrating peptide fusion protein, is prepared by following steps:
The single bacterium colony of recombination engineered strain Escherichia coli BL21 (DE3) pET-32a-PEP-1-CD46
It is inoculated in the 20ml LB fluid nutrient mediums containing ampicillin (final concentration of 100 μ g/ml), in 37 DEG C of shaking tables, 300rpm
Shaking is incubated overnight 10~12h.By 1:100 ratio is inoculated into the fresh lactose automatic induction culture medium ZYM5052 of 20ml
(Amp+) in, 37 DEG C of constant temperature, 300rpm cultures 3h or so.Under aseptic condition, 1ml bacterium solutions are taken as the control before induction.It moves again
Low temperature induction is carried out to 16 DEG C of culture shaking tables, induces 16h automatically.12000g is centrifuged, 4 DEG C, 10min collects thalline, with 20ml's
Lysis Buffer are resuspended thalline and carry out ultrasonic disruption, supernatant are collected by centrifugation and with SDS-PAGE electrophoresis detection destination proteins
Expression.Further expand and cultivate, after ultrasonic disruption, 12000g, 4 DEG C of centrifugations, 20min collection precipitations.
Application of the PEP-1-CD46 fusion proteins in the malicious valency for improving Virus culture, including fusion protein PEP-1-
Applications of the CD46 in the production of high quality swine fever virus cell vaccine, application process are as follows:
After ST cells grow up to fine and close individual layer in Tissue Culture Flask, cell maintenance medium is outwelled, first with the pancreas egg of 5ml 0.25%
Then white enzyme solutions cleaning cell surface adds the trypsin solution vitellophag of 5ml 0.25%, treat cell aggregation into
Trypsin solution is outwelled by group when starting shedding off, add in 8ml cell growth mediums and terminate digestion, blow and beat mixing, expect blue dyeing with platform
Viable count is carried out, adds suitable cell growth medium, adjusts cell density to 1 × 105A/ml.Cell growth medium is accessed
In 96 well culture plates, 200 μ l are added in per hole, each group repeats for 12 holes, 37 DEG C, 5.0%CO2Under the conditions of quiescent culture.And it sets
Blank control wells are not added with any liquid.37 DEG C, 5.0%CO2Under the conditions of quiescent culture.Treat that cell growth is covered to 75%~80%
It during lid culture plate culture plane, inhales abandon culture solution in each hole in superclean bench, 20 μ l viruses maintaining liquids (virus is accessed per hole
Control group is cell maintenance medium), according to 0.1MOI dose inoculation virus liquids, and meanwhile it is above-mentioned by the final concentration addition of 40ng/ml
PEP-1-CD46 fusion proteins, 37 DEG C, 5.0%CO2Under the conditions of adsorb 1h after, viral maintaining liquid is accessed per hole to 200 μ l (viruses
Control group is cell maintenance medium), 37 DEG C, 5.0%CO2Under the conditions of quiescent culture.
Swine fever virus culture poison valency prepared by the present invention can reach 108.4TCID50/ml, available for swine fever attenuated cell
The production of seedling.
Compared with prior art, the present invention has the following advantages:
1) fusion protein PEP-1-CD46 expression quantity according to the present invention is big, and is soluble protein, convenient for extensive
Production, of low cost, operating procedure is simple;
2) present invention utilizes Bacillus coli expression PEP-1 nexin transduction domains and the fusion egg of swine fever virus receptor CD46
In vain, it is intended that capture the swine fever virus in culture solution by CD46 albumen, then by PEP-1 albumen membrane penetration effect by the pig of capture
Pestivirus is brought into the cell, makes swine fever virus is imported to intracellular progress as much as possible by force in a short time in cultivating system
Amplification, achievees the purpose that increase substantially swine fever virus culture potency.
3) method provided by the invention for improving swine fever virus culture potency can be solved in current swine fever virus cell vaccine
Viral level is low, the shortcomings that being not achieved with seedling standard.TCID50 methods measure its culture potency and can reach 108.4TCID50/ml is high
The weak malicious culture of swine fever of potency can be used for the classical swine fever virus vaccine for preparing high quality.
Description of the drawings
Fig. 1 is the one step growth curve that CSFV is proliferated in ST cells.
Specific embodiment
Below in conjunction with the accompanying drawings and specific embodiment the invention will be further described.All trainings being related in embodiment
It supports base and molecular biology manipulations method is well known to those skilled in the art.The involved molecular biology method of this experiment is
Conventional method is familiar with by those skilled in the art.What is do not elaborated in the present invention refers to《Molecular Cloning:A Laboratory guide》J. Sa
The chief editors such as nurse Brooker, D.W. Russells.
Embodiment 1:PEP-1-CD46 genes it is artificial synthesized
According to CD46 (the Gene ID delivered in GeneBank:396922) sequence and the sequence of PEP-1 is manually closed
Into PEP-1-CD46 genes, and add EcoR I, BamH I's restriction enzyme site respectively at its both ends, the gene order of synthesis includes S
Coding region sequence shown in EQ ID NO.1.
Embodiment 2:
The structure of recombinant plasmid pET-32a-PEP-1-CD46
With restriction enzyme EcoR I, BamH I's double digestion carrier pET-32a plasmids and PEP-1-CD46cDNA.Digestion
System is as follows:
Endonuclease reaction condition is 37 DEG C, 2~3 hours of reaction time.Digestion products are returned through agarose gel electrophoresis with glue
Receive kit recycling open loop pET-32a and PEP-1-CD46cDNA endonuclease bamhi.
PEP-1-CD46cDNA endonuclease bamhis with open loop pET-32a are connected, obtain recombinant plasmid pET-32a-PEP-1-C
D46.Linked system is as follows:
Coupled reaction liquid mixing, when 22 DEG C of coupled reactions 2 are small, store in 4 DEG C it is spare.
Calcium Chloride Method prepares competent escherichia coli cell, and step is:
1) on fresh solid LB tablets picking DH5 α single bacterium colony, be inoculated in 20ml LB fluid nutrient mediums, 37 DEG C are shaken
Bed 300rpm overnight incubations.
2) the 200 μ l bacterium solutions that inoculation is activated overnight are in fresh 20ml LB fluid nutrient mediums, 37 DEG C, 300rpm cultures
About 2~3h, until OD600About 0.4~0.6.
3) under gnotobasis, bacterium solution is drawn into the 1.5ml EP pipes of precooling, 4 DEG C of centrifugations, 4000rpm, 10min.It abandons
Clear culture solution collects thalline.
4) the 0.1M CaCl per effective 200 μ l precoolings2Solution is resuspended, ice bath 30 minutes.
5) 4 DEG C of centrifugations, 4000rpm, 10min abandon supernatant culture solution, collect thalline, be placed on ice.
6) the 0.1M CaCl per effective 100 μ l precoolings2Solution is resuspended, and competent cell is prepared and finished.
Connection product converts competent escherichia coli cell:Its step is:
1) 10 μ l of connection product is taken to add in 100 μ l competent cells under aseptic condition, gently mixing, ice bath 30min.
2) 42 DEG C of water-bath heat shock 90s move to rapidly on ice, cool down 1~2min.
3) 600 μ l LB fluid nutrient mediums are added in, the 150rpm jogs in 37 DEG C of shaking tables incubate 45min,
4) 4000rpm is centrifuged 10 minutes, is left 100 μ l supernatants, is discarded remaining bacterium solution, and thalline is resuspended with pipettor.
5) above-mentioned bacterium solution is spread evenly across containing Amp with sterile triangle spreading rod+(final concentration of 100 μ g/ml's)
On LB tablets, forward direction is placed, and after liquid is fully absorbed, is inverted tablet, 37 DEG C of overnight incubations.
Thus E.coli DH5 α pET-32a-PEP-1-CD46 bacterium colonies can be prepared in method.
The digestion identification of positive forward direction recon pET-32a-PEP-1-CD46:
E.coli DH5 α pET-32a-PEP-1-CD46 plasmids are extracted with alkaline lysis a small amount of (15-20ug), to institute's upgrading
Grain carries out single endonuclease digestion and double digestion, digestion system are as follows:
The single endonuclease digestion of recombinant plasmid pET-32a-PEP-1-CD46
The double digestion of recombinant plasmid pET-32a-PEP-1-CD46
Endonuclease reaction condition is 37 DEG C, and 2-3 hour of reaction time, digestion products are detected with agarose gel electrophoresis,
The specific band that two sizes are respectively 5900bp and 1173bp is obtained, size is consistent with theoretical value, shows successfully to build weight
Group plasmid pET-32a-PEP-1-CD46.
Embodiment 3:The preparation of Recombinant organism
By plasmid pET-32a-PEP-1-CD46 (1ul) conversion e. coli bl21s (DE3) competent cell.PCR is identified
Positive transformant is filtered out, gained positive colony is the recombination of the present invention for being capable of amalgamation and expression PEP-1-CD46
Engineered strain Escherichia coli BL21 (DE3)pET-32a-PEP-1-CD46.The bacterium is in being preserved in December, 2014
It send within 5th to China typical culture collection center and carries out preservation, deposit number is CCTCC NO:M2014631, address:It is Chinese military
Chinese Wuhan University, Classification And Nomenclature:Escherichia coli BL21(DE3)/pET-32a–CSFR.
Embodiment 4:The expression of genetic engineering fusion protein PEP-1-CD46
1) from solid LB (Amp+) picking carries the E.c of plasmid pET-32a and pET-32a-PEP-1-CD46 on tablet
Oli BL21 (DE3) single bacterium colony is inoculated in the 20ml LB fluid nutrient mediums containing ampicillin (final concentration of 100 μ g/ml)
In, in 37 DEG C of shaking tables, 300rpm shakings are incubated overnight 10~12h.
2) second day, the strain of activation is pressed 1:100 ratio is transferred in lactose automatic induction culture medium ZYM5052,
37 DEG C, when 300rpm shaken cultivations 3~4 are small.Under aseptic condition, 1ml bacterium solutions are taken as the control before induction.
3) 16 DEG C are then moved to, 300rpm culture shaking tables carry out low temperature induction, induce 16h automatically.
4) 4 DEG C of centrifugations, 12000rpm, 5min abandon supernatant, collect thalline.
5) the Lysis Buffer that 20ml is added in into the bacterial sediment of collection are resuspended.
6) bacteria suspension is placed in -20 DEG C of multigelations and carries out ultrasonication afterwards several times, 400W, working time 3s, during interval
Between 3s.
7) when bacteria suspension becomes limpid by muddiness, show that thalline is substantially broken complete, stop ultrasonication.
8) bacterial cell disruption liquid is centrifuged into 20min in 4 DEG C, 12000rpm.
9) supernatant of centrifugation gained is collected, takes 20 μ L and isometric 2 × SDS-PAGE sample buffer mixings, sample
It is placed in boiling water and boils 10min, carry out SDS-PAGE.
10) after electrophoresis, gel is unloaded, after dyeing 2-4h with Coomassie brilliant blue dye liquor, then with destainer by background colour
Until taking off, to determine whether PEP-1-CD46 albumen is expressed.
SDS-PAGE shows that obtaining a size in supernatant after fusion protein PEP-1-CD46 bacterial cell disruptions is about
The specific band of 46KD shows successful expression PEP-1-CD46 albumen, the sequence of the destination protein PEP-1-CD46 given expression to
It is classified as shown in SEQ ID NO.2.
Embodiment 5:The purifying of genetic engineering fusion protein PEP-1-CD46
Supernatant in Ni-NTA Superflow columns affinity chromatography purifying embodiment 4 after bacterial cell disruption obtained by centrifugation,
Its step are as follows:
1) 1ml Ni-NTA Agarose are drawn with pipettor and is packed into chromatography column bottom, washed with the distilled water of 10 times of column volumes
Wash pillar.
2) with the Lysis Buffer balance nickel columns of 10 times of column volumes.
3) by the good protein solution of renaturation after 0.45 μm of membrane filtration, with peristaltic pump with the rate of 1ml/min, add in
Into the nickel pillar balanced, make the 6-His and Ni of albumen front end2+Fully combine.
4) successively with suitable Imidazole containing 20mM, 40mM Imidazole, 60mM Imidazole, 80mM I
The Wash Buffer of midazole elute pillar with the rate of 1ml/min, to elute lower Ni2+It is combined on column unstable or few
Amount not with Ni2+With reference to non-destination protein.The OD of the efflux after elution every time is detected with nucleic acid-protein detector280, treat OD280
Stop washing when being continuously 0.
5) pillar is eluted with the rate of 200 μ l/min with the Elution Buffer of the Imidazole containing 250mM, used
Eppen dorf pipes collect destination protein.The albumen of collection is taken to carry out 12%SDS-PAGE detection purification effects.
6) SDS-PAGE electrophoresis is carried out, detects the purification effect of collected albumen, expression quantity is big, and is soluble egg
In vain, protein concentration is about 627 μ g/ml.
Embodiment 6:
Immunofluorescence test PEP-1-CD46 fusion proteins improve the research of swine fever virus culture potency
(1) prepared by cell
After ST cells grow up to fine and close individual layer in Tissue Culture Flask, cell maintenance medium is outwelled, first with the pancreas egg of 5ml 0.25%
Then white enzyme solutions cleaning cell surface adds the trypsin solution vitellophag of 5ml 0.25%, treat cell aggregation into
Trypsin solution is outwelled by group when starting shedding off, add in 8ml cell growth mediums and terminate digestion, blow and beat mixing, expect blue dyeing with platform
Viable count is carried out, adds suitable cell growth medium, adjusts cell density to 1 × 105A/ml.Cell growth medium is accessed
In 96 well culture plates, 200 μ l are added in per hole, each group repeats for 12 holes, 37 DEG C, 5.0%CO2Under the conditions of quiescent culture.
(2) viruses adsorption
When the culture plane of cell growth to 75%~80% covering cell culture well, inhale completely in superclean bench
Culture solution in each hole is abandoned, adds each group cell hole of PEP-1-CD46 fusion protein groups, 20 PEP-s of the μ l containing addition are accessed per hole
The cell maintenance medium of 1-CD46 fusion proteins, make addition PEP-1-CD46 fusion protein final concentrations respectively reach 20ng/ml,
40ng/ml and 60ng/ml, according to 0.1MOI dose inoculation hog cholera venom.Cell controls are set simultaneously, only access 20 μ l cells dimension
Liquid is held, not virus inoculation.Virus control group accesses cells of the 20 μ l without addition PEP-1-CD46 fusion proteins per hole and maintains
Liquid, according to 0.1MOI dose inoculation virus liquids, each group sets 12 hole of parallel hole.Tissue Culture Plate is placed in 37 DEG C, 5.0%CO2Item
1h is adsorbed under part.180 μ l virus-culturing fluids (cell controls group and virus control group addition cell dimension are accessed after absorption per hole
Hold liquid), it is placed in 37 DEG C, 5.0%CO2Under the conditions of quiescent culture.
(3) it is fixed
After viruses adsorption 20min, 30min, 40min, 60min, 90min, 180min, 210min, 12h, 15h,
18h, 21h, for 24 hours, 36h, 48h, 60h, 72h, 84h, 96h and 108h respectively take 1 piece of cell plates, with the soft board-washings 2 of the PBS of pH7.2
It after secondary, inhale abandon liquid completely, 30min is fixed with 80% acetone of -20 DEG C of cooling 10min.
(4) fluorescent antibody staining
After outwelling acetone, with pH7.2PBS board-washings 2 times, each 10min.After board-washing, room temperature naturally dry connects per hole
Enter the 30 μ l of pig pestivirus fluorescence antibody working solution diluted, be put into wet box, be protected from light under the conditions of 37 DEG C and be incubated 40min.
(5) fluorescence microscopy
After incubation, liquid, pH7.2PBS board-washings 2 times are outwelled, drying is placed under fluorescence microscope and amplifies 200 times of sights
It examines.It tests and sets up when cell controls group unstressed configuration particle occurs.Utilize fluorescence after fluorescence colour detection addition PEP-1-CD46
It is outer in the cell the variation of speed occur, illustrate to add PEP-1-CD46 to viruses adsorption, wear the shadow of film speed and albumen synthesis
It rings, measures the titre of culture solution generation of neutrons virus, make the one step growth curve that swine fever virus is proliferated in ST cells, analysis adds
PEP-1-CD46 is added to improve the effect of virus titer.
1 Immunofluorescence test of table
Note:- represent not observe fluorescent grain ,+represent that a small amount of fluorescent grain can be observed, fluorescent brightness is smaller, ++ table
Show and more fluorescent grain can be observed, fluorescent brightness is larger.
PEP-1-CD46 accelerates viruses adsorption and wears the speed of film as can be seen from Table 1, promotes the synthesis of virus protein,
And viruses adsorption also increased with the virion quantity for wearing film.Wherein add 40ng/ml PEP-1-CD46 experimental groups virus
Absorption 30min just has virion to be combined with receptor-specific on cell membrane, and absorption 90min just has a large amount of virion completions to wear
Membrane process is into the cell, and 18h just has new virus protein synthesis, addition 20ng/ml, 60ng/ml PEP-1- after virus inoculation
The CD46 experimental group viruses adsorption times are slower, and virus control group then just has a viral specific adsorption in 60min, during 90min
Only a small amount of virion completion wears membrane process into the cell, and 21h just has new virus protein synthesis.
PEP-1-CD46 can significantly improve titre viral in culture solution as seen from Figure 1, infect 60h virus titers
Reach top.Wherein, addition 40ng/ml PEP-1-CD46 experimental groups can make the titre of virus be up to 108.4TCID50/
Ml, lower slightly addition 20ng/ml, 60ng/ml PEP-1-CD46 experimental group virus titers (are respectively 107.4TCID50/ml and
107.6TCID50/ml), but still higher than the titre of virus control group (titre of virus control group is 107.1TCID50/ml).This is carried
Show that we add the fusion protein of suitable concentration and can effectively facilitate multiplication rates of the CSFV in ST cells, so as to improve disease
Toxic effect valency.
SEQUENCE LISTING
<110>Wuhan Inst of Veterinary Science
<120>A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application
<130>A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application
<160> 2
<170> PatentIn version 3.1
<210> 1
<211> 1173
<212> DNA
<213>Artificial sequence
<400> 1
aaggaaacat ggtgggaaac gtggtggact gagtggtccc agcctaaaaa gaagagaaag 60
gtttctgctc caggtacccc tatgatggct ttctgtgctt tgcgtaaagc tctgccatgt 120
cgtccagaaa acccattttc ttctcgttgt ttcgtcgaaa tattgtgggt ttctttggct 180
ttggtttttc tattgccaat gccttctgat gcctgtgatg aaccacccaa gtttgaatct 240
atgagaccac agttcttaaa cactacttat aggccaggtg atagagtcga atacgaatgt 300
agacctggtt ttcaaccaat ggttccagcc ttgccaactt tttctgtttg ccaagacgat 360
aatacttggt ctccattgca agaagcttgt aggagaaaag cttgctctaa tttgccagat 420
ccattgaacg gtcaagtttc ttacccaaat ggtgacatgt tgtttggttc taaagcccaa 480
tttacgtgta acacaggttt ttacattatt ggtgctgaaa ctgtttactg ccaagtctct 540
ggtaatgtca tggcatggtc cgaaccctct cccttgtgtg aaaagatttt gtgtaagcca 600
cccggtgaaa ttcctaacgg taagtacact aactctcata aggatgtttt tgagtataac 660
gaggtcgtta cttactcttg tttgtcttcc acgggaccag atgagttttc cttggttggt 720
gaatcttctc tgttttgtat aggtaaggac gaatggtctt ctgacccacc cgagtgtaag 780
gttgttaagt gcccataccc agttgttccc aacggagaaa ttgttagtgg tttcggttca 840
aagttctatt acaaagcaga agtcgtattt aagtgtaacg ccggttttac tttgcatggt 900
agagatacta ttgtctgtgg tgctaattct acttgggagc cagaaatgcc acaatgtatt 960
aaggattcta aaccaactga tccaccagct actcctggtc catcccatcc aggcccaccc 1020
tccccatcag atgcttctcc accaaaggat gctgaatcat tggacggtgg tattatagcc 1080
gctattgttg ttggtgtttt agctgcaata gctgtcattg ctggaggtgt gtatttcttc 1140
catcacaaat acaacaaaaa gaggtctaag taa 1173
<210> 2
<211> 390
<212> PRT
<213>Artificial sequence
<400> 2
Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys
1 5 10 15
Lys Lys Arg Lys Val Ser Ala Pro Gly Thr Pro Met Met Ala Phe Cys
20 25 30
Ala Leu Arg Lys Ala Leu Pro Cys Arg Pro Glu Asn Pro Phe Ser Ser
35 40 45
Arg Cys Phe Val Glu Ile Leu Trp Val Ser Leu Ala Leu Val Phe Leu
50 55 60
Leu Pro Met Pro Ser Asp Ala Cys Asp Glu Pro Pro Lys Phe Glu Ser
65 70 75 80
Met Arg Pro Gln Phe Leu Asn Thr Thr Tyr Arg Pro Gly Asp Arg Val
85 90 95
Glu Tyr Glu Cys Arg Pro Gly Phe Gln Pro Met Val Pro Ala Leu Pro
100 105 110
Thr Phe Ser Val Cys Gln Asp Asp Asn Thr Trp Ser Pro Leu Gln Glu
115 120 125
Ala Cys Arg Arg Lys Ala Cys Ser Asn Leu Pro Asp Pro Leu Asn Gly
130 135 140
Gln Val Ser Tyr Pro Asn Gly Asp Met Leu Phe Gly Ser Lys Ala Gln
145 150 155 160
Phe Thr Cys Asn Thr Gly Phe Tyr Ile Ile Gly Ala Glu Thr Val Tyr
165 170 175
Cys Gln Val Ser Gly Asn Val Met Ala Trp Ser Glu Pro Ser Pro Leu
180 185 190
Cys Glu Lys Ile Leu Cys Lys Pro Pro Gly Glu Ile Pro Asn Gly Lys
195 200 205
Tyr Thr Asn Ser His Lys Asp Val Phe Glu Tyr Asn Glu Val Val Thr
210 215 220
Tyr Ser Cys Leu Ser Ser Thr Gly Pro Asp Glu Phe Ser Leu Val Gly
225 230 235 240
Glu Ser Ser Leu Phe Cys Ile Gly Lys Asp Glu Trp Ser Ser Asp Pro
245 250 255
Pro Glu Cys Lys Val Val Lys Cys Pro Tyr Pro Val Val Pro Asn Gly
260 265 270
Glu Ile Val Ser Gly Phe Gly Ser Lys Phe Tyr Tyr Lys Ala Glu Val
275 280 285
Val Phe Lys Cys Asn Ala Gly Phe Thr Leu His Gly Arg Asp Thr Ile
290 295 300
Val Cys Gly Ala Asn Ser Thr Trp Glu Pro Glu Met Pro Gln Cys Ile
305 310 315 320
Lys Asp Ser Lys Pro Thr Asp Pro Pro Ala Thr Pro Gly Pro Ser His
325 330 335
Pro Gly Pro Pro Ser Pro Ser Asp Ala Ser Pro Pro Lys Asp Ala Glu
340 345 350
Ser Leu Asp Gly Gly Ile Ile Ala Ala Ile Val Val Gly Val Leu Ala
355 360 365
Ala Ile Ala Val Ile Ala Gly Gly Val Tyr Phe Phe His His Lys Tyr
370 375 380
Asn Lys Lys Arg Ser Lys
385 390
Claims (1)
- A kind of 1. method for improving swine fever virus infection titre, which is characterized in that thin with cell growth medium culture swine fever virus ST Born of the same parents by the use of the fusion protein that genetic engineering bacterium is expressed as Virus culture accelerating agent, add in cell maintenance medium, are inoculated with hog cholera Poison improves the virus titer of cell culture swine fever virus;The fusion protein is CCTCC NO by deposit number:The bacterial strain of M2014631 expresses to obtain.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410776634.6A CN104530241B (en) | 2014-12-15 | 2014-12-15 | A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410776634.6A CN104530241B (en) | 2014-12-15 | 2014-12-15 | A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104530241A CN104530241A (en) | 2015-04-22 |
CN104530241B true CN104530241B (en) | 2018-05-18 |
Family
ID=52845898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410776634.6A Expired - Fee Related CN104530241B (en) | 2014-12-15 | 2014-12-15 | A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104530241B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112143748A (en) * | 2020-10-13 | 2020-12-29 | 陕西科技大学 | Protein extraction method without cell lysis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10313865A (en) * | 1997-05-15 | 1998-12-02 | Deinabetsuku Kenkyusho:Kk | Vector exhibiting human complement-controlling factor |
WO2007089946A2 (en) * | 2006-02-03 | 2007-08-09 | Karp Nelson M | Animal model for hiv induced disease |
CN102311500A (en) * | 2010-07-02 | 2012-01-11 | 杭州师范大学 | Antiviral fusion protein and application thereof |
CN103314012A (en) * | 2010-08-20 | 2013-09-18 | 李尚揆 | Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
-
2014
- 2014-12-15 CN CN201410776634.6A patent/CN104530241B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10313865A (en) * | 1997-05-15 | 1998-12-02 | Deinabetsuku Kenkyusho:Kk | Vector exhibiting human complement-controlling factor |
WO2007089946A2 (en) * | 2006-02-03 | 2007-08-09 | Karp Nelson M | Animal model for hiv induced disease |
CN102311500A (en) * | 2010-07-02 | 2012-01-11 | 杭州师范大学 | Antiviral fusion protein and application thereof |
CN103314012A (en) * | 2010-08-20 | 2013-09-18 | 李尚揆 | Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
Non-Patent Citations (1)
Title |
---|
猪瘟病毒E2蛋白结合细胞受体的鉴定;常天明;《中国优秀硕士学位论文全文数据库农业科技辑》;20110215(第02期);23,24,27,28,36 * |
Also Published As
Publication number | Publication date |
---|---|
CN104530241A (en) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104404074B (en) | The preparation method of hoof-and-mouth disease virus capsid protein series connection coexpression and virus-like particle | |
CN108159409A (en) | A kind of 3 type Cap protein vaccine of pig circular ring virus and its preparation method and application | |
CN111393531B (en) | Subunit fusion protein CD2V-Fc and preparation method and application thereof | |
CN104178505B (en) | A kind of expression E 2 gene of Classical Swine Fever recombinant virus and preparation method and application | |
CN103122352A (en) | Porcine circovirus II-type recombinant baculovirus as well as preparation method and application thereof | |
CN109601007A (en) | A kind of foot and mouth disease virus sample particle vaccines and preparation method thereof | |
CN110317278A (en) | The fusion protein and its encoding gene of SVV and FMDV, expression vector, cell line, engineering bacteria and vaccine and application | |
CN110128508A (en) | A kind of aviadenovirus fiber protein subunit vaccine | |
CN107987135A (en) | 4 type aviadenovirus subunit protein of Ι groups, its preparation method and application | |
CN109536460A (en) | A kind of CV-A10 virus seed culture of viruses and its inactivated vaccine for human | |
CN107227311A (en) | Recombination porcine parvovirus like-particles and its preparation method and application | |
CN108624609A (en) | It is used to prepare the nucleic acid construct and method of coxsackie virus A 16-type virus-like particle | |
CN102304529B (en) | Preparation method of rabbit hemorrhagic fever virus empty capsid antigen | |
CN104530241B (en) | A kind of genetic engineering bacterium for expressing cell-penetrating peptide fusion protein and application | |
CN104530230B (en) | A kind of duck hepatitis A virus VP1 GFPs and its application | |
CN102604993B (en) | Immunologic adjuvant-Helicobacter pylori antigen fused protein oral vaccine and preparation method thereof | |
CN106554965A (en) | For preparing the nucleic acid construct and method of EV71 virus-like particles | |
CN104726429A (en) | Bacteriophage lysin with improved antibacterial effect | |
CN104744595B (en) | Anti- GCHV engineered protein TAT VP7 TAT and preparation method and application | |
CN106008678A (en) | Fusion protein for inhibiting clostridium perfringens infection and related biological material and application thereof | |
CN115010812B (en) | Multimeric of African swine fever antigen-mediated cellular immunity and application thereof | |
CN110128545A (en) | A kind of fusion, recombinant expression carrier, antigen and its preparation method and application | |
CN107325188A (en) | The construction method of the Chinese hamster ovary celI strain of pig blood Albumin Fusion pig circular ring virus Cap2 albumen and its application | |
CN107164252A (en) | A kind of RHDV subunit vaccine | |
CN103421729B (en) | Gene recombined swine cholera salmonella choleraesuis vaccine for blue-ear disease and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180518 Termination date: 20201215 |